AKRO icon

Akero Therapeutics

79 hedge funds and large institutions have $545M invested in Akero Therapeutics in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more capital invested

Capital invested by funds: $ → $

0.86% less ownership

Funds ownership: 77.1%76.24% (-0.86%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

76% less call options, than puts

Call options by funds: $206K | Put options by funds: $869K

Holders
79
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$206K
Puts
$869K
Net Calls
Net Calls Change

Top Buyers

1 +$7.72M
2 +$5.82M
3 +$4.12M
4
CS
Candriam SCA
Luxembourg
+$3.44M
5
Morgan Stanley
Morgan Stanley
New York
+$3.35M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$252K
52
$221K
53
$217K
54
$204K
55
$193K
56
$170K
57
$152K
58
$139K
59
$96.2K
60
$70K
61
$55K
62
$49K
63
$46K
64
$38K
65
$37K
66
$36K
67
$36K
68
$27K
69
$22K
70
$19K
71
$18K
72
$18K
73
$18K
74
$10.7K
75
$9K